Skip to main content
Investors
Investors Menu

Investors

Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

Press release | Financial news
August 8, 2024

Separation activities and business continuity on track Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3% GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56...

Read more

stock ticker
NYSESOLV
Company overview

A new healthcare company with a rich history

With more than 70 years of delivering healthcare innovations, we continue to move the industry forward by helping to solve our customers’ biggest challenges.

  • $8.2 billionin sales in 2023
  • Approximately 22,000professionals shaping the future of health
Events & Presentations
Events Businessperson speaking at microphone in front of crowd
Solventum Corp. Q3 2024 Earnings
Thursday, November 7, 2024
4:30pm - 5:30pm EST
Add to Calendar
Set Email Reminder

See all events

Press releases
Press release
Oct 15, 2024
Solventum to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024

Solventum (NYSE: SOLV) will release its third quarter 2024 financial results on Thursday, November 7, 2024 after the U.S. financial markets close. The company will also host a conference call that...

Read more

Press release
Oct 14, 2024
Solventum Announces Commitment to 100% Renewable Electricity by 2030

Solventum (NYSE: SOLV), formerly 3M Health Care, today pledges to use 100% renewable electricity across its worldwide operations by 2030. This move highlights Solventum's commitment to...

Read more

Press release
Aug 28, 2024
Solventum to Participate in Upcoming Investor Conferences

Solventum (NYSE: SOLV) executives plan to participate in the following investor conferences: 2024 Wells Fargo Healthcare Conference in Everett, MA on Wednesday, September 4, 2024 at 11:00 a.m. ET....

Read more

See all financial news

Resources

We enable better, smarter, safer healthcare to improve lives

Learn more about our priorities and how we are uniquely positioned to transform healthcare.

Governance

Read about our governance priorities and our commitment to accountability.

View governance

Leadership

Meet our corporate officers and board of directors.

View leadership

SEC filings

Find information and links to statements filed with the SEC.

View SEC filings

Media center

Discover our latest news and announcements.

View media center

Investor alerts

Sign up today and receive company updates straight to your inbox.

Subscribe

Contact Investor Relations

These contacts are intended only for shareholders. If you are not a shareholder, please call 1-855-423-6725 (1-855-HC FOR ALL).

General inquiries:
investors@solventum.com

Contact us

Transfer agent contact information:

EQ Shareowner Services
P.O. Box 64854
St. Paul, MN 55164-0854
Toll Free: 1-888-666-0140   
Tel: 1-651-450-4064 (outside the United States)

An automated voice response system is available 24 hours a day, 7 days a week. Customer service representatives are available from 7:00 a.m. to 7:00 p.m., Central Standard Time, Monday through Friday.

Account information
https://www.shareowneronline.com